EquityZen Growth Technology Fund LLC - Series 97
Raised
$351K
Investors
19
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 97 is a pooled investment fund vehicle filed by EquityZen on 2017-04-13, raising $351K from 19 investors under Rule 506(b) and Section 3(c)(1) exemptions. This entity is part of the EquityZen platform, which operates nearly 1,900 related pre-IPO secondary market vehicles. Minimum investment and first sale date were not disclosed in this filing.
This pre-IPO fund operates under the standard 506(b)/3(c)(1) exemption combination typical of private secondary market vehicles, allowing up to 35 non-accredited investors alongside accredited participants. The modest $351K raise across 19 investors (~$18.5K average commitment) reflects EquityZen's fractional access model for individual accredited investors seeking exposure to private growth companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Jens Beyrich
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
